BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22964958)

  • 21. Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial.
    Bakhshi S; Batra A; Biswas B; Dhawan D; Paul R; Sreenivas V
    Support Care Cancer; 2015 Nov; 23(11):3229-37. PubMed ID: 25851802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis.
    Dumot JA; Conwell DL; Zuccaro G; Vargo JJ; Shay SS; Easley KA; Ponsky JL
    Am J Gastroenterol; 2001 Jul; 96(7):2098-102. PubMed ID: 11467638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.
    Sherman S; Cheng CL; Costamagna G; Binmoeller KF; Puespoek A; Aithal GP; Kozarek RA; Chen YK; Van Steenbergen W; Tenner S; Freeman M; Monroe P; Geffner M; Deviere J;
    Pancreas; 2009 Apr; 38(3):267-74. PubMed ID: 19214137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study.
    Prat F; Amaris J; Ducot B; Bocquentin M; Fritsch J; Choury AD; Pelletier G; Buffet C
    Gastrointest Endosc; 2002 Aug; 56(2):202-8. PubMed ID: 12145597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
    Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D
    Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitis.
    Fluhr G; Mayerle J; Weber E; Aghdassi A; Simon P; Gress T; Seufferlein T; Mössner J; Stallmach A; Rösch T; Müller M; Siegmund B; Büchner-Steudel P; Zuber-Jerger I; Kantowski M; Hoffmeister A; Rosendahl J; Linhart T; Maul J; Czakó L; Hegyi P; Kraft M; Engel G; Kohlmann T; Glitsch A; Pickartz T; Budde C; Nitsche C; Storck K; Lerch MM
    BMC Gastroenterol; 2013 Jan; 13():11. PubMed ID: 23320650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
    Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
    Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IV Ibuprofen for Prevention of Post-ERCP Pancreatitis in Children: A Randomized Placebo-controlled Feasibility Study.
    Troendle DM; Gurram B; Huang R; Barth BA
    J Pediatr Gastroenterol Nutr; 2020 Jan; 70(1):121-126. PubMed ID: 31651801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-ERCP infusion of semapimod, a mitogen-activated protein kinases inhibitor, lowers post-ERCP hyperamylasemia but not pancreatitis incidence.
    van Westerloo DJ; Rauws EA; Hommes D; de Vos AF; van der Poll T; Powers BL; Fockens P; Dijkgraaf MG; Bruno MJ
    Gastrointest Endosc; 2008 Aug; 68(2):246-54. PubMed ID: 18455169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial.
    Yoo JW; Ryu JK; Lee SH; Woo SM; Park JK; Yoon WJ; Lee JK; Lee KH; Hwang JH; Kim YT; Yoon YB
    Pancreas; 2008 Nov; 37(4):366-70. PubMed ID: 18953247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study.
    Albany C; Brames MJ; Fausel C; Johnson CS; Picus J; Einhorn LH
    J Clin Oncol; 2012 Nov; 30(32):3998-4003. PubMed ID: 22915652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis.
    Katsinelos P; Kountouras J; Paroutoglou G; Beltsis A; Mimidis K; Zavos C
    Gastrointest Endosc; 2005 Jul; 62(1):105-11. PubMed ID: 15990827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Ishiwatari H; Urata T; Yasuda I; Matsusaki S; Hisai H; Kawakami H; Ono M; Iwashita T; Doi S; Kawakubo K; Hayashi T; Sonoda T; Sakamoto N; Kato J
    Dig Dis Sci; 2016 Nov; 61(11):3292-3301. PubMed ID: 27447477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
    Devière J; Le Moine O; Van Laethem JL; Eisendrath P; Ghilain A; Severs N; Cohard M
    Gastroenterology; 2001 Feb; 120(2):498-505. PubMed ID: 11159890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.
    Poon RT; Yeung C; Liu CL; Lam CM; Yuen WK; Lo CM; Tang A; Fan ST
    Gut; 2003 Dec; 52(12):1768-73. PubMed ID: 14633959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis.
    Budzyńska A; Marek T; Nowak A; Kaczor R; Nowakowska-Dulawa E
    Endoscopy; 2001 Sep; 33(9):766-72. PubMed ID: 11558030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study.
    Geraci G; Palumbo VD; D'Orazio B; Maffongelli A; Fazzotta S; Lo Monte AI
    Clin Ter; 2019; 170(5):e332-e336. PubMed ID: 31612188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial.
    Poon RT; Yeung C; Lo CM; Yuen WK; Liu CL; Fan ST
    Gastrointest Endosc; 1999 May; 49(5):593-8. PubMed ID: 10228257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography.
    Buxbaum J; Yan A; Yeh K; Lane C; Nguyen N; Laine L
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):303-7.e1. PubMed ID: 23920031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aprepitant for antiemesis after laparoscopic gynaecological surgery: A randomised controlled trial.
    Ham SY; Shim YH; Kim EH; Son MJ; Park WS; Lee JS
    Eur J Anaesthesiol; 2016 Feb; 33(2):90-5. PubMed ID: 26694939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.